Torrent Carnisure Syrup for Dogs and Cats, 30ml

Targeted Correction of Primary Carnitine Deficiency:
Carnisure 500 mg Syrup directly replenishes the systemic and intracellular levocarnitine pool in children diagnosed with primary carnitine deficiency, a condition caused by mutations in the OCTN2 carnitine transporter gene that severely limit renal carnitine reabsorption and tissue uptake. By raising plasma and tissue carnitine concentrations toward physiological norms, the syrup restores mitochondrial fatty acid oxidation and alleviates the clinical manifestations of deficiency, including hypoglycaemia, muscle weakness, and hypoketotic encephalopathy.

Metabolic Support in Secondary Carnitine Deficiency Conditions:
In children with inherited organic acidaemias, fatty acid oxidation disorders, and other metabolic conditions that secondarily deplete carnitine, Carnisure targets the root metabolic imbalance by restoring the free carnitine pool and promoting the urinary excretion of accumulated toxic acylcarnitine species. This dual action helps normalise the acyl-CoA to free CoA ratio within cells, protecting enzymatic function and reducing the metabolic crisis burden in vulnerable paediatric patients.

Cardiac and Skeletal Muscle Energy Restoration:
The heart and skeletal muscles are among the most metabolically active organs in the body and are heavily reliant on fatty acid oxidation for their sustained energy demands. Carnisure supports cardiomyocyte and myocyte mitochondrial function by ensuring an adequate supply of levocarnitine for fatty acid transport, thereby alleviating carnitine-associated cardiomyopathy and muscle hypotonia in deficient children, and reducing the risk of progressive cardiac functional decline.

Renal Disease Adjunct for Dialysis-Dependent Patients:
Haemodialysis and peritoneal dialysis effectively clear levocarnitine from the blood with each session, placing dialysis-dependent patients at high risk of progressive carnitine depletion. Carnisure 500 mg Syrup addresses this iatrogenic deficit by restoring carnitine levels between dialysis sessions, potentially improving muscle function, energy metabolism, anaemia of chronic kidney disease, and cardiac status in patients managed on dialysis.

Convenient Paediatric Oral Liquid Formulation:
The syrup format of Carnisure ensures easy dose measurement and administration for infants, young children, and older paediatric patients who cannot swallow tablets. The liquid preparation allows for flexibility in dosing as prescribed by the treating physician, and the syrup can be mixed with a small amount of food or liquid to improve palatability, encouraging consistent compliance in paediatric populations.

How to Use:

Carnisure 500 mg Syrup must only be used as directed by a qualified physician or paediatrician. Before administering each dose, shake the bottle well to ensure the active ingredient is uniformly distributed throughout the syrup. Use the measuring device supplied with the bottle to measure the exact prescribed volume accurately, never approximating with household spoons.

Storage Advice:

Store unopened Carnisure 500 mg Syrup in a cool, dry place below 30 degrees Celsius, away from direct sunlight and sources of heat. Do not freeze. Once opened, keep the bottle tightly closed at all times and store under the same conditions, using the remaining syrup within the period advised by your physician or as indicated on the label. Always keep this product out of reach of children. Do not use after the best-before date printed on the bottle label.

About the Brand:

Torrent Pharmaceuticals was founded in 1959 in Ahmedabad, India, by Shri U. N. Mehta as Trinity Laboratories, and was rechristened Torrent Pharmaceuticals in 1971, going on to become one of India's most respected pharmaceutical companies with a presence in over 50 countries and more than 2,000 product registrations globally. The company holds international manufacturing accreditations including EU-GMP certification, USFDA compliance, and ISO-certified quality management systems, and is consistently ranked among the top five pharmaceutical companies in India across multiple therapeutic segments including paediatrics, cardiovascular care, and vitamins, minerals, and nutritional supplements. Torrent's product development philosophy is anchored in robust, in-house R&D conducted by a team of over 800 scientists, with a commitment to delivering clinically validated formulations that meet the highest standards of efficacy and safety. The company's enduring dedication to quality manufacturing, social responsibility through the UNM Foundation, and improving patient outcomes across diverse populations aligns with Animeal's commitment to offering only rigorously tested, veterinarian-trusted healthcare products for your pet's wellbeing. Discover Torrent Pharmaceuticals today.

Disclaimer:

Please note that while Carnisure 500 mg Syrup is formulated from levocarnitine, a naturally occurring amino acid derivative, and is appropriate for paediatric patients diagnosed with primary or secondary carnitine deficiency, it is a Schedule H prescription medicine and must not be purchased or administered without a valid prescription from a registered medical practitioner. This product is a complementary nutritional supplement and is not a replacement for prescribed therapy, dietary management, or specialist medical supervision in metabolic disorders. For children with seizure disorders, severe renal impairment, diabetes, or those taking anticoagulant or thyroid hormone replacement medications, consult your child's physician before introducing or continuing this product, as clinically significant interactions may occur. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.